• +385 91 525-8267
  • info@onkolab.hr
logo
  • NASLOVNICA
  • O NAMA
  • CARIS LIFE SCIENCES
  • PROIZVODI
  • KAKO NARUČITI?
  • KONTAKT
  • NASLOVNICA
  • O NAMA
  • CARIS LIFE SCIENCES
  • PROIZVODI
  • KAKO NARUČITI?
  • KONTAKT

Novosti

  • Home
  •  
  • Novosti
    • 28 KOL. 17
    • 0

    Caris Life Sciences’ Molecular Intelligence Platform Identifies Patients with MSI-High (or Mismatch Repair Deficient) Solid Tumors More Likely to Respond to Immunotherapy

    Results Published in Science Demonstrate Molecular Profile of Tumor Cells Rather than Tumor Origin Can Drive Therapeutic Strategy IRVING, Texas, June 8, 2017 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today highlighted an article published in Science containing data on microsatellite instability (MSI) status and mismatch repair (MMR)-deficient tumors on a

    Read more →
    • Posted in
    • Novosti
    • Posted by
    • Onkolab
    • 28 KOL. 17
    • 0

    Caris Life Sciences’ Molecular Intelligence Reports Optimized for the American Society of Clinical Oncology, Inc. TAPUR Study

    Caris Molecular Intelligence Tumor Profiling Reports Optimized to Molecularly Identify Genomic Alterations for the TAPUR Study IRVING, Texas, June 8, 2017 – Caris Life Sciences®, a leading innovator in molecular science, and the American Society of Clinical Oncology, Inc. (ASCO®), announced that Caris is one of the first laboratories to have a test report optimized for ASCO’s

    Read more →
    • Posted in
    • Novosti
    • Posted by
    • Onkolab
    • 28 KOL. 17
    • 0

    Caris Life Sciences, National Cancer Institute and ECOG-ACRIN Collaborate to Molecularly Identify Candidates for the NCI-MATCH Clinical Trial

    Caris to Participate in Next-Generation Sequencing Concordance Evaluation with NCI-MATCH Trial Laboratory Network IRVING, Texas, June 7, 2017 – Caris Life Sciences®, a leading innovator in molecular science, today announced a collaboration with the National Cancer Institute (NCI) for the NCI-Molecular Analysis for Therapy Choice (NCI-MATCH or EAY131) precision medicine trial, which is being implemented by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN).

    Read more →
    • Posted in
    • Novosti
    • Posted by
    • Onkolab
    • 28 KOL. 17
    • 0

    Caris Life Sciences’ Molecular Intelligence Platform Characterizes Total Mutational Load in Multiple Tumor Types

    7,000 Tumor Database with Total Mutational Load Status Used to Identify Cancer Types that May Respond to Immunotherapies Platform Enables Detailed Profiling of Total Mutational Load Status and Correlation with Tumor Types Data Presented in Poster Discussion and Poster Session at the 2017 ASCO Annual Meeting IRVING, Tex., June 5, 2017 – Caris Life Sciences®, a leading innovator

    Read more →
    • Posted in
    • Novosti
    • Posted by
    • Onkolab
    • 28 KOL. 17
    • 0

    Caris Life Sciences’ Molecular Intelligence Platform Measures Prevalence of Oncogenic Homologous Recombination Pathway Mutations across 53,000 Tumors

    Results have Wide Applicability for Personalized Medicine and Drug Discovery and Development Data presented in Oral Abstract Session at the 2017 ASCO Annual Meeting IRVING, Tex., June 5, 2017 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced results of a molecular profiling analysis to identify the

    Read more →
    • Posted in
    • Novosti
    • Posted by
    • Onkolab
  • 1
  • 2
  • 3
  • ›
  • »
  • Caris Life Sciences®

    Saznaj Više

  • Molecular Intelligence®

    Saznaj Više

  • Novosti

    Saznaj Više

O Nama:

OnkoLab je mikro poduzeće osnovano 2015. godine kao rezultat entuzijazma stručnjaka u području molekularne biologije, a kao posljedica gubitka voljenih ljudi i nemogućnosti da im se pomogne u izboru najuspješnijeg liječenja.

Kako oboljeli u RH ne bi prolazili isto, na teritorij RH i okolne regije dovedena je vodeća kompanija u području molekularnog profiliranja.

Saznaj Više

Kako do Nas:

Za dodatne informacije molimo Vas da nas kontaktirate putem uputnika koji se nalazi na kontakt stranici.

  • Mobitel: +385 91 525-8267

  • E-mail: info@onkolab.hr

  • Ili ispunite upitnik na kontakt stranici

Brzi linkovi:

Saznajte više o molekularnom profiliranju tumora.

  • My Cancer

  • My Cancer genome

  • European Society For Medical Oncology

  • National Comprehensive Cancer Network

  • Cancer

  • Hrvatsko Onkološko Društvo

  • National Cancer Institute

2016 © Copyright - Onkolab.hr developed by Hr-Webdesign.com
Top